Now viewable online and soon to be published in Diabetes Care is a position statement on hypoglycemia, issued by the American Diabetes Association in tandem with the European Association for the Study of Diabetes (EASD).
The U.S. association plans to print the report in its January 2017 journal, with details on diagnosing and documenting the condition characterized by abnormally low blood glucose. The article will be published by both the American Diabetes Association and the European Association for the Study of Diabetes.
"We formed our multidisciplinary group three years ago with a goal to increase awareness of hypoglycemia as a major side effect of current treatment in diabetes,” Simon Heller, professor of clinical diabetes at University of Sheffield, said. "We developed the idea that a re-classification of hypoglycemia would be useful and are delighted that both the American Diabetes Association and EASD have agreed."
The International Study Group determined specific levels denoting clinically significant levels of hypoglycemia independent of symptoms in order to assay clinical trial results, classifying the disorder into three distinct phases or tiers -- labeling them as levels 1 through 3, with 3 being the most severe type.
Published monthly as the journal of the Arlington, Virginia-based American Diabetes Association, Diabetes Care aims to disseminate knowledge, spur research and support improved health for diabetics.
